FGFR3 is a negative regulator of the expansion of pancreatic epithelial cells

Diabetes

Volumn 56, Issue 1, 2007, Pages 96-106

  Arnaud Dabernat, Sandrine ^a,b   Kritzik, Marcie ^a   Kayali, Ayse G ^a   Zhang, You Qing ^a   Liu, Guoxun ^a   Ungles, Cory ^a   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 9; FIBROBLAST GROWTH FACTOR RECEPTOR 3; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL CULTURE; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; EPITHELIUM CELL; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NEWBORN; NEWBORN PERIOD; NONHUMAN; ORGAN GROWTH; PANCREAS CELL; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEM CELL; TISSUE DISTRIBUTION; TISSUE REGENERATION;

AGING; ANIMALS; ANIMALS, NEWBORN; CELL LINE; EPITHELIAL CELLS; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; PANCREAS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; REGENERATION; SIGNAL TRANSDUCTION;

EID: 33847068767     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db05-1073     Document Type: Article

References (55)

1. Slack JM: Developmental biology of the pancreas. Development 121:1569-1580, 1995
2. Zhang YQ, Sarvetnick N: Development of cell markers for the identification and expansion of islet progenitor cells. Diabete Metab Res Rev 19:363-374, 2003
3. Holland AM, Gonez LJ, Harrison LC: Progenitor cells in the adult pancreas. Diabete Metab Res Rev 20:13-27, 2004
4. Gittes GK, Galante PE, Hanahan D, Rutter WJ, Debase HT: Lineage-specific morphogenesis in the developing pancreas: role of mesenchymal factors. Development 122:439-447, 1996
5. Kim SK, MacDonald RJ: Signaling and transcriptional control of pancreatic organogenesis. Curr Opin Genet Dev 12:540-547, 2002
6. Hebrok M, Kim SK, Melton DA: Notochord repression of endodermal Sonic hedgehog permits pancreas development. Genes Dev 12:1705-1713, 1998
7. Le Bras S, Miralles F, Basmaciogullari A, Czernichow P, Scharfmann R: Fibroblast growth factor 2 promotes pancreatic epithelial cell proliferation via functional fibroblast growth factor receptors during embryonic life. Diabetes 47:1236-1242, 1998
8. Arany E, Hill DJ: Ontogeny of fibroblast growth factors in the early development of the rat endocrine pancreas. Pediatr Res 48:389-403, 2000
9. Hart A, Papadopoulou S, Edlund H: Fgf10 maintains notch activation, stimulates proliferation, and blocks differentiation of pancreatic epithelial cells. Dev Dyn 228:185-193, 2003
10. Yamaoka T, Yoshino K, Yamada T, Yano M, Matsui T, Yamaguchi T, Moritani M, Hata J, Noji S, Itakura M: Transgenic expression of FGF8 and FGF10 induces transdifferentiation of pancreatic islet cells into hepatocytes and exocrine cells. Biochem Biophys Res Commun 292:138-143, 2002
11. Dichmann DS, Miller CP, Jensen J, Scott Heller R, Serup P: Expression and misexpression of members of the FGF and TGFbeta families of growth factors in the developing mouse pancreas. Dev Dyn 226:663-674, 2003
12. Bhushan A, Itoh N, Kato S, Thiery JP, Czernichow P, Bellusci S, Scharfmann R: Fgf10 is essential for maintaining the proliferative capacity of epithelial progenitor cells during early pancreatic organogenesis. Development 128:5109-5117, 2001
13. Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M: Receptor specificity of the fibroblast growth factor family. J Biol Chem 271:15292-15297, 1996
14. Shimizu A, Tada K, Shukunami C, Hiraki Y, Kurokawa T, Magane N, Kurokawa-Seo M: A novel alternatively spliced fibroblast growth factor receptor 3 isoform lacking the acid box domain is expressed during chondrogenic differentiation of ATDC5 cells. J Biol Chem 276:11031-11040, 2001
15. Cras-Meneur C, Scharfmann R: FGFR1-IIIb is a putative marker of pancreatic progenitor cells. Mech Dev 116:205-208, 2002
16. Hart AW, Baeza N, Apelqvist A, Edlund H: Attenuation of FGF signalling in mouse beta-cells leads to diabetes. Nature 408:864-868, 2000
17. Elghazi L, Cras-Meneur C, Czernichow P, Scharfmann R: Role for FGFR2IIIb-mediated signals in controlling pancreatic endocrine progenitor cell proliferation. Proc Natl Acad Sci U S A 99:3884-3889, 2002
18. Pulkkinen MA, Spencer-Dene B, Dickson C, Otonkoski T: The IIIb isoform of fibroblast growth factor receptor 2 is required for proper growth and branching of pancreatic ductal epithelium but not for differentiation of exocrine or endocrine cells. Mech Dev 120:167-175, 2003
19. Hughes SE: Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues. J Histochem Cytochem 45:1005-1019, 1997
20. Colvin JS, Bohne BA, Harding GW, McEwen DG, Ornitz DM: Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet 12:390-397, 1996
21. Li C, Chen L, Iwata T, Kitagawa M, Fu XY, Deng CX: A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. Hum Mol Genet 8:35-44, 1999
22. Lievens PM, Liboi E: The thanatophoric dysplasia type II mutation hampers complete maturation of fibroblast growth factor receptor 3 (FGFR3), which activates signal transducer and activator of transcription 1 (STAT1) from the endoplasmic reticulum. J Biol Chem 278:17344-17349, 2003
23. Martinelli G, Tosi P, Ottaviani E, Soverini S, Tura S: Molecular therapy for multiple myeloma. Haematologica 86:908-917, 2001
24. Dailey L, Laplantine E, Priore R, Basilico C: A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation. J Cell Biol 161:1053-1066, 2003
25. Oh LY, Denninger A, Colvin JS, Vyas A, Tole S, Ornitz DM, Bansal R: Fibroblast growth factor receptor 3 signaling regulates the onset of oligodendrocyte terminal differentiation. J Neurosci 23:883-894, 2003
26. Mueller KL, Jacques BE, Kelley MW: Fibroblast growth factor signaling regulates pillar cell development in the organ of corti. J Neurosci 22:9368-9377, 2002
27. Sarvetnick N, Liggitt D, Pitts SL, Hansen SE, Stewart TA: Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 52:773-782, 1988
28. Monsonego-Ornan E, Adar R, Feferman T, Segev O, Yayon A: The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation. Mol Cell Biol 20:516-522, 2000
29. Scharfmann R, Basmaciogullari A, Czernichow P: Effect of growth hormone and glucose on rat islet cells replication using 5-bromo-2-deoxyuridine incorporation. Diabetes Res 15:137-141, 1990
30. Zhang YQ, Kanzaki M, Furukawa M, Shibata H, Ozeki M, Kojima I: Involvement of Smad proteins in the differentiation of pancreatic AR42J cells induced by activin A. Diabetologia 42:719-727, 1999
31. Efrat S, Fusco-DeMane D, Lemberg H, al Emran O, Wang X: Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci U S A 92:3576-3580, 1995
32. Kayali AG, Van Gunst K, Campbell IL, Stotland A, Kritzik M, Liu G, Flodstrom-Tullberg M, Zhang YQ, Sarvetnick N: The stromal cell-derived factor-1alpha/CXCR4 ligand-receptor axis is critical for progenitor survival and migration in the pancreas. J Cell Biol 163:859-869, 2003
33. Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA: Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest 108:1631-1638, 2001
34. Kritzik MR, Jones E, Chen Z, Krakowski M, Krahl T, Good A, Wright C, Fox H, Sarvetnick N: PDX-1 and Msx-2 expression in the regenerating and developing pancreas. J Endocrinol 163:523-530, 1999
35. Kritzik MR, Krahl T, Good A, Krakowski M, St-Onge L, Gruss P, Wright C, Sarvetnick N: Transcription factor expression during pancreatic islet regeneration. Mol Cell Endocrinol 164:99-107, 2000
36. Gu D, Sarvetnick N: Epithelial cell proliferation and islet neogenesis in IFN-g transgenic mice. Development 118:33-46, 1993
37. Simon MA: Receptor tyrosine kinases: specific outcomes from general signals. Cell 103:13-15, 2000
38. Priore R, Dailey L, Basilico C: Downregulation of Akt activity contributes to the growth arrest induced by FGF in chondrocytes. J Cell Physiol 207:800-808, 2006
39. Guz Y, Montminy MR, Stein R, Leonard J, Gamer LW, Wright CV, Teitelman G: Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development 121:11-18, 1995
40. Bonner-Weir S, Toschi E, Inada A, Reitz P, Fonseca SY, Aye T, Sharma A: The pancreatic ductal epithelium serves as a potential pool of progenitor cells. Pediatr Diabetes 5 (Suppl. 2):16-22, 2004
41. Lin HT, Chiou SH, Kao CL, Shyr YM, Hsu CJ, Tarng YW, Ho LL, Kwok CF, Ku HH: Characterization of pancreatic stem cells derived from adult human pancreas ducts by fluorescence activated cell sorting. World J Gastroenterol 12:4529-4535, 2006
42. Kanai M, Rosenberg I, Podolsky DK: Cytokine regulation of fibroblast growth factor receptor 3 IIIb in intestinal epithelial cells. Am J Physiol 272:G885-G893, 1997
43. Melloul D: Transcription factors in islet development and physiology: role of PDX-1 in beta-cell function. Ann N Y Acad Sci 1014:28-37, 2004
44. Rozenblatt-Rosen O, Mosonego-Ornan E, Sadot E, Madar-Shapiro L, Sheinin Y, Ginsberg D, Yayon A: Induction of chondrocyte growth arrest by FGF: transcriptional and cytoskeletal alterations. J Cell Sci 115:553-562, 2002
45. Kinkl N, Ruiz J, Vecino E, Frasson M, Sahel J, Hicks D: Possible involvement of a fibroblast growth factor 9 (FGF9)-FGF receptor-3-mediated pathway in adult pig retinal ganglion cell survival in vitro. Mol Cell Neurosci 23:39-53, 2003
46. Norgaard GA, Jensen JN, Jensen J: FGF10 signaling maintains the pancreatic progenitor cell state revealing a novel role of Notch in organ development. Dev Biol 264:323-338, 2003
47. Liu Z, Xu J, Colvin JS, Ornitz DM: Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev 16:859-869, 2002
48. Santos-Ocampo S, Colvin JS, Chellaiah A, Ornitz DM: Expression and biological activity of mouse fibroblast growth factor-9. J Biol Chem 271:1726-1731, 1996
49. Alizadeh M, Miyamura N, Handa JT, Hjelmeland LM: Human RPE cells express the FGFR2IIIc and FGFR3IIIc splice variants and FGF9 as a potential high affinity ligand. Exp Eye Res 76:249-256, 2003
50. Garofalo S, Kliger-Spatz M, Cooke JL, Wolstin O, Lunstrum GP, Moshkovitz SM, Horton WA, Yayon A: Skeletal dysplasia and defective chondrocyte differentiation by targeted overexpression of fibroblast growth factor 9 in transgenic mice. J Bone Miner Res 14:1909-1915, 1999
51. Jamal AM, Lipsett M, Hazrati A, Paraskevas S, Agapitos D, Maysinger D, Rosenberg L: Signals for death and differentiation: a two-step mechanism for in vitro transformation of adult islets of Langerhans to duct epithelial structures. Cell Death Differ 10:987-996, 2003
52. Petersen HV, Jensen JN, Stein R, Serup P: Glucose induced MAPK signalling influences NeuroD1-mediated activation and nuclear localization. FEBS Lett 528:241-245, 2002
53. Naya FJ, Huang HP, Qiu Y, Mutoh H, DeMayo FJ, Leiter AB, Tsai MJ: Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev 11:2323-2334, 1997
54. Montero JA, Ganan Y, Macias D, Rodriguez-Leon J, Sanz-Ezquerro JJ, Merino R, Chimal-Monroy J, Nieto MA, Hurle JM: Role of FGFs in the control of programmed cell death during limb development. Development 128:2075-2084, 2001
55. Zhu L, Somlo G, Zhou B, Shao J, Bedell V, Slovak ML, Liu X, Luo J, Yen Y: Fibroblast growth factor receptor 3 inhibition by short hairpin RNAs leads to apoptosis in multiple myeloma. Mol Cancer Ther 4:787-798, 2005